Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: EZZ Life Science Holdings Limited

Capitalization 48.01M 34.05M 29.54M 26.71M 25.5M 46.39M 3.14B 318M 126M 1.5B 128M 125M 5.42B P/E ratio 2024
11.4x
P/E ratio 2025 16.1x
Enterprise value 26.57M 18.85M 16.35M 14.78M 14.12M 25.67M 1.74B 176M 69.86M 831M 70.73M 69.22M 3B EV / Sales 2024
0.94x
EV / Sales 2025 1.33x
Free-Float
30.68%
Yield 2024
1.9%
Yield 2025 1.71%
1 day-0.49%
1 week-6.42%
Current month-33.77%
1 month-37.04%
3 months-31.77%
6 months-54.67%
Current year-27.66%
1 week 1.02
Extreme 1.02
1.16
1 month 1.02
Extreme 1.02
1.72
Current year 1.02
Extreme 1.02
2.4
1 year 1.02
Extreme 1.02
3.38
3 years 0.38
Extreme 0.38
4.97
5 years 0.27
Extreme 0.27
4.97
10 years 0.27
Extreme 0.27
4.97
Manager TitleAgeSince
Chief Executive Officer - 08/10/2021
Corporate Officer/Principal - 02/12/2025
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 27/10/2020
Director/Board Member - 27/10/2020
Director/Board Member - 16/01/2026
Change 5d. change 1-year change 3-years change Capi.($)
-0.49%-6.42%-35.44%+142.86% 34.22M
-1.60%+15.12%+76.41%+110.62% 17.5B
-1.74%-1.38%-19.03%+267.64% 6.19B
-0.09%+2.38%-3.65%-47.56% 2.84B
-0.24%-4.00%-74.80%-43.83% 1.96B
+1.61%+4.70%+32.42%-19.12% 1.66B
-0.30%-1.81%+88.23%-18.38% 1.57B
+0.22%+2.59% - - 1.56B
+0.17%-10.13%-58.07%-59.98% 1.33B
+1.09%-4.03%+22.46%+15.88% 1.03B
Average -0.14%-2.23%+3.17%+38.68% 3.57B
Weighted average by Cap. -1.00%+2.15%+35.16%+95.33%

Financials

2024 2025
Net sales 66.44M 47.13M 40.88M 36.96M 35.29M 64.2M 4.35B 440M 175M 2.08B 177M 173M 7.5B 66.87M 47.43M 41.15M 37.2M 35.52M 64.61M 4.38B 443M 176M 2.09B 178M 174M 7.55B
Net income 6.96M 4.94M 4.29M 3.87M 3.7M 6.73M 456M 46.11M 18.31M 218M 18.54M 18.14M 787M 6.73M 4.77M 4.14M 3.74M 3.58M 6.5M 441M 44.56M 17.69M 211M 17.91M 17.53M 760M
Net Debt -19.46M -13.8M -11.97M -10.82M -10.33M -18.8M -1.27B -129M -51.15M -609M -51.78M -50.68M -2.2B -21.44M -15.2M -13.19M -11.93M -11.39M -20.71M -1.4B -142M -56.36M -671M -57.06M -55.84M -2.42B
Logo EZZ Life Science Holdings Limited
EZZ Life Science Holdings Limited is an Australian genomic life science company. The Company has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), children's health, and weight management. The Company's segments include Brought in Lines and Company Owned products. Its portfolio includes EZZ and EAORON. The EZZ-branded product range encompasses a broad selection of health and wellbeing products, catering to individuals across all age groups and owned by the Company. The EAORON-branded products comprise a range of facial care items, and the Company serves as the exclusive distributor in Australia and New Zealand for selected channels. The EZZ-branded products include EZZ Hair Growth Spray Duo, EZZ Multi Vitamins Milk Powder for Children (for children ages three plus), EZZ KidzSure Formulated Nutrition Powder (for children ages three plus) and EZZ VitalSure Formulated Nutrition Powder (for adults).
Employees
-
Date Price Change Volume
13/03/26 1.020 $ -0.49% 2,128
12/03/26 1.025 $ -1.91% 25,980
11/03/26 1.045 $ -1.42% 16,591
10/03/26 1.060 $ +2.91% 45,558
09/03/26 1.030 $ -5.07% 56,104

Annual profits - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW